Tag: FDA

March 5, 2026

Drug Approval Dilemma: Weighing Risk & Benefit in Rare Diseases | STAT+

March 3, 2026

Prime Medicine Seeks FDA Approval for First Prime Editing Gene Therapy

March 3, 2026

FDA Breakthrough Designation Signals Path for AI Chatbots in Healthcare Recovery

March 2, 2026

UniQure’s Huntington’s Disease Therapy Faces FDA Delay | STAT+ Exclusive

March 2, 2026

FDA Defends Rare Disease Drug Rejections, Backs Official Under Fire

March 2, 2026

FDA’s New Pathway Offers Hope for Rare Disease Gene Therapies